These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 25380841)
1. A linear relationship between serum high-sensitive C-reactive protein and hemoglobin in hemodialysis patients. Heidari B; Fazli MR; Misaeid MA; Heidari P; Hakimi N; Zeraati AA Clin Exp Nephrol; 2015 Aug; 19(4):725-31. PubMed ID: 25380841 [TBL] [Abstract][Full Text] [Related]
2. The influence of inflammatory markers and CRP predictive value in relation to the target hemoglobin level in patients on chronic hemodialysis. Musanovic A; Trnacevic S; Mekic M; Musanovic A Med Arch; 2013; 67(5):361-4. PubMed ID: 24601173 [TBL] [Abstract][Full Text] [Related]
3. Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study. Ogawa C; Tsuchiya K; Tomosugi N; Kanda F; Maeda K; Maeda T PLoS One; 2017; 12(6):e0179608. PubMed ID: 28662118 [TBL] [Abstract][Full Text] [Related]
4. The Content of Reticulocyte Hemoglobin and Serum Concentration of the Soluble Transferrin Receptor for Diagnostics of Anemia in Chronically Hemodialyzed Patients. Kurzawa T; Owczarek A; Strzelczyk JK; Gołąbek K; Wiczkowski A Adv Clin Exp Med; 2016; 25(3):425-31. PubMed ID: 27629729 [TBL] [Abstract][Full Text] [Related]
5. Serum hepcidin levels in patients with end-stage renal disease on hemodialysis. Rubab Z; Amin H; Abbas K; Hussain S; Ullah MI; Mohsin S Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):19-25. PubMed ID: 25579711 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of C-reactive protein in patients on hemodialysis: a longitudinal study. Teruel JL; Marcen R; Ocaña J; Fernández-Lucas M; Rivera M; Tabernero G; Ortuño J Nephron Clin Pract; 2005; 100(4):c140-5. PubMed ID: 15855797 [TBL] [Abstract][Full Text] [Related]
7. C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients. Yılmaz I; Ozkok A; Kostek O; Kolukısa A; Duran I; Odabaş AR; Kemal Işman F; Işbilen Başok B Ren Fail; 2016; 38(1):89-95. PubMed ID: 26539647 [TBL] [Abstract][Full Text] [Related]
8. Inflammation and iron status in bariatric surgery candidates. Careaga M; Moizé V; Flores L; Deulofeu R; Andreu A; Vidal J Surg Obes Relat Dis; 2015; 11(4):906-11. PubMed ID: 25862176 [TBL] [Abstract][Full Text] [Related]
9. Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease. Ahbap E; Sakaci T; Kara E; Sahutoglu T; Koc Y; Basturk T; Sevinc M; Akgol C; Kayalar AO; Ucar ZA; Bayraktar F; Unsal A Clin Nephrol; 2016 Apr; 85(4):199-208. PubMed ID: 26521887 [TBL] [Abstract][Full Text] [Related]
10. Credibility of the measurement of serum ferritin and transferrin receptor as indicators of iron deficiency anemia in hemodialysis patients. Mahdavi MR; Makhlough A; Kosaryan M; Roshan P Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1158-62. PubMed ID: 22165676 [TBL] [Abstract][Full Text] [Related]
12. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Owen WF; Lowrie EG Kidney Int; 1998 Aug; 54(2):627-36. PubMed ID: 9690231 [TBL] [Abstract][Full Text] [Related]
13. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Attallah N; Osman-Malik Y; Frinak S; Besarab A Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942 [TBL] [Abstract][Full Text] [Related]
14. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients. Chen YC; Hung SC; Tarng DC Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299 [TBL] [Abstract][Full Text] [Related]
15. Iron status biomarkers and C-reactive protein in children aged 19 to 72 months in Chile. Brito A; Hertrampf E; Olivares M Food Nutr Bull; 2013 Mar; 34(1):14-20. PubMed ID: 23767277 [TBL] [Abstract][Full Text] [Related]
16. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients. El-Khatib M; Duncan HJ; Kant KS Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552 [TBL] [Abstract][Full Text] [Related]
17. Linkage of elevated CaxPO4 product with inflammation in maintenance hemodialysis patients. Nasri H Minerva Urol Nefrol; 2006 Dec; 58(4):339-45. PubMed ID: 17268399 [TBL] [Abstract][Full Text] [Related]
18. Serum ferritin level remains a reliable marker of bone marrow iron stores evaluated by histomorphometry in hemodialysis patients. Rocha LA; Barreto DV; Barreto FC; Dias CB; Moysés R; Silva MR; Moura LA; Draibe SA; Jorgetti V; Carvalho AB; Canziani ME Clin J Am Soc Nephrol; 2009 Jan; 4(1):105-9. PubMed ID: 18842949 [TBL] [Abstract][Full Text] [Related]
19. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study. Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum C-reactive protein level and its related factors in hemodialysis patients in Sari, Iran. Baradari AG; Emami Zeydi A; Espahbodi F; Shahmohammadi S Pak J Biol Sci; 2011 May; 14(10):595-9. PubMed ID: 22097096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]